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INTRODUCTION
Biliary cast formation almost always occurs in 
orthotopically transplanted livers as a consequence 
of complications. Biliary cast formation in non-
transplanted livers is rare. However, in the past few years, 
gastroenterologists in Germany have observed and reported 
on an unusual sclerosing cholangitis in patients who have 
recovered from life-threatening disease in intensive care 
units (ICUs). This newly described entity has been named 
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sclerosing cholangitis in critically ill patients (SC-CIP) (1-
4). This new disorder is unfamiliar to many radiologists, 
and no reports focusing on the radiological findings 
associated with biliary cast formation in SC-CIP have 
been published. We report a case of biliary cast formation 
with SC-CIP and describe the computed tomography (CT), 
magnetic resonance cholangiopancreatography (MRCP), and 
endoscopic retrograde cholangiography (ERC) findings. 
CASE REPORT
A 68-year-old man was transferred to our hospital for 
further evaluation of cryptogenic organizing pneumonia 
(COP). He had a six-week history of intermittent chills, 
myalgia, general weakness, and dyspnea. A contrast-
enhanced chest CT acquired at a local medical center was 
reviewed by the chest radiologist at our hospital, whose 
first impression was also COP. Histologic confirmation 
was obtained by wedge resection via video-assisted 
thoracoscopic surgery (VATS). The patient received 
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aggressive ICU treatment for COP with acute respiratory 
distress syndrome (ARDS), including positive end 
expiratory pressures (PEEP) mode mechanical ventilation. 
The patient did not have hypotension severe enough to 
require administering vasopressors, such as epinephrine 
or norepinephrine. Three weeks later, blood tests in the 
ICU revealed elevated alanine transaminase (ALT, 126 U/
L) and alkaline phosphatase (ALP, 463 IU/L) levels but a 
normal total bilirubin level. The patient did not have any 
past medical history of hepatobiliary disease; therefore, 
the clinician suspected drug-induced hepatitis. The patient 
underwent abdominal ultrasound to exclude obstructive 
bile duct pathology or underlying chronic liver disease. 
An abdominal ultrasound revealed a slightly coarse 
parenchymal echotexture in the liver and a sludge ball 









Fig. 1. 68-year-old man with biliary cast formation with sclerosing cholangitis in critically ill patients.
A. Contrast-enhanced axial computed tomography (CT) scan (5 mm slice thickness, portal phase) is suspicious of multifocal strictures and 
irregularities (arrows) in left intrahepatic duct (IHD). B. Contrast-enhanced axial CT scan (5 mm slice thickness, 3 min delayed phase) is 
suspicious of diffuse mild wall thickening (arrowheads) with increased intraluminal attenuation in right main IHD. C. 3D MIP magnetic resonance 
cholangiopencreatography image also reveals multiple strictures, irregularity, and beaded appearance in both IHDs. Elongated intraluminal filling 
defect, which indicates biliary cast (arrow) in proximal common bile duct (CBD) is seen. D. Heavily T2-weighted axial image shows intraductal 
filling defect, which is representative of biliary cast, in proximal CBD (arrow). E. Endoscopic removal of biliary cast after sphincterotomy. 
Endoscopic image shows black pigmented biliary cast that was retrieved through ampulla of Vater by basket. F. Seven weeks after initial 
cholestasis, ERC shows multifocal strictures, irregular dilatations in both IHD and biliary casts (arrow) in peripheral IHD. G, H. After 6 months, 
thin section contrast-enhanced axial CT scan (1.5 mm slice thickness, portal phase) and coronal scan (5 mm slice thickness) more clearly shows 
multiple irregular strictures and dilatations (arrowheads) in both IHD. Korean J Radiol 13(3), May/Jun 2012 kjronline.org 360
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bile duct (IHD) or common bile duct (CBD) dilatation. 
Two weeks later, a contrast-enhanced abdominal CT was 
performed, due to increased ALP elevation, and a total 
bilirubin level of 4.39 mg/dL was observed. The contrast-
enhanced abdominal CT showed suspicious multifocal 
strictures and irregularities in both IHDs and diffuse mild 
wall thickening with increased intraluminal attenuation 
in the right main IHD, which can be misinterpreted as a 
partial volume averaging effect (Fig. 1A, B). There was no 
evidence of thrombus formation or stenosis in the hepatic 
artery, portal vein, or hepatic vein. Our first impression was 
sclerosing cholangitis with bile sludge. We also considered 
Immunoglobulin G4-related sclerosing disease because 
combined interstitial pneumonia and sclerosing cholangitis 
can appear in that disorder. However, manifestation of 
IgG4-related sclerosing disease as sclerosing cholangitis 
without autoimmune pancreatitis is unusual, and IgG and 
IgG4 levels were normal. We reviewed the previous contrast-
enhanced chest CT performed by the abdominal radiologist. 
There was no notable abnormality visualized in the 
hepatobiliary system on that CT. The presumed sclerosing 
cholangitis was newly developed during the hospitalization. 
MRCP was performed for further evaluation of the suspicious 
increased intraluminal attenuation in the right main IHD, 
which was needed for the ERC-assisted procedure by some 
possibility, and for the diagnosis of sclerosing cholangitis. 
The MRCP showed multiple strictures, irregularity, and a 
beaded appearance in both IHDs. There was an elongated 
intraluminal filling defect in both central IHDs that 
extended to the proximal CBD, which was suggestive of 
biliary casts in sclerosing cholangitis (Fig. 1C, D). The ERC 
revealed a diffuse, amorphous, elongated filling defect in 
both the central IHD and proximal CBD. A black-pigmented 
biliary cast was retrieved through the ampullar of Vater 
by basket (Fig. 1E). The patient was diagnosed as having 
biliary cast formation with SC-CIP. Further blood tests 
revealed improvements in the obstructive jaundice after the 
procedure, and the patient was discharged from the hospital 
after having received aggressive treatment including 
mechanical ventilation, for a total of six weeks. 
One month later, a follow-up blood test administered 
on an outpatient basis again revealed an elevated total 
bilirubin level (8.60 mg/dL). The newly appeared biliary 
casts in both the IHDs and CBD were seen on MRCP, and 
the biliary casts were retrieved by basket on ERC. However, 
biliary casts were also noted from the central to the 
peripheral IHDs, and these casts could not be completely 
removed by basket (Fig. 1F). A contrast-enhanced 
abdominal CT performed 6 months later found clearer 
indications of multiple irregular strictures and dilatations 
in both IHDs (Fig. 1G, H). The patient is currently receiving 
ursodeoxycholic acid (UDCA) treatment.
DISCUSSION
Biliary cast formation almost always occurs in 
orthotopically transplanted livers and is associated with 
ischemic injury to the biliary epithelium. It occurs in 3% 
to 18% of orthotopic liver transplantations and results in 
biliary obstruction with infection and secondary hepatocyte 
and bile duct damage (5). The exact pathogenesis of cast 
development is unclear. It has been suggested that multiple 
etiological factors, such as biliary infection, bile duct 
damage, ischemia, fasting, and hemolysis, play roles in cast 
formation (5). Biliary cast formation in non-transplanted 
livers is rare, and there are a limited number of case 
reports of patients who had emergent cholecystectomy or 
antiphospholipid antibody syndrome (6). In our opinion, 
all of these previous cases may now be seen to have been 
SC-CIP, considering the clinical histories and imaging 
findings. SC-CIP is a recently described entity that occurs 
as a long-term complication in ICU patients during or after 
recovery from life-threatening illness. It is characterized 
by persistent, progressive cholestasis and findings of 
sclerosing cholangitis on cholangiography (1, 3, 4). The 
pathogenesis of SC-CIP is still under discussion. The most 
accepted pathogenesis involves arterial hypoperfusion of 
the perivascular plexus, and leads to ischemic injury of 
the bile duct epithelium, which is exclusively supplied 
by the perivascular plexus; biliary cast formation and 
subsequent biliary infection follow (1, 3, 7, 8). Accordingly, 
many SC-CIP cases require mechanical ventilation with 
high PEEP mode for severe respiratory problems or a high 
dose of vasoconstrictors, which can disturb the patient’s 
hepatosplanchnic hemodynamics.
Clinical signs during the initial phases of SC-CIP are not 
specific and are similar to those of endotoxin-associated 
jaundice. SC-CIP usually begins with rapidly increasing 
serum levels of ALP and gamma-glutamyl transferase (GGT), 
as well as elevated serum bilirubin levels. However, the 
degree of bilirubin elevation is often less pronounced than 
that of ALP and GGT (1, 7). Despite apparent recovery from 
the primary illness, persistent cholestasis is observed, and 
this is the main clinical finding that discriminates SC-CIP Korean J Radiol 13(3), May/Jun 2012 kjronline.org 361
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from other types of cholestasis (7). Jaeger et al. (4) have 
reported that the initial cholestasis is noted at a median of 
6.5 days (with a range of 4-11 days) after the initial injury, 
and Gelbmann et al. (1) have reported that elevated ALP 
and GGT levels are observed at a mean of 9.4 ± 6.1 days (with 
a range of 4-31 days) after the beginning of mechanical 
ventilation.
The histological characteristics of SC-CIP have been 
described by Gelbmann et al. (1), Scheppach et al. (2), 
and Benninger et al. (3). In the first 1-3 months after the 
initial cholestasis, the histological features of SC-CIP are 
quite variable and can range from mild, nonspecific changes 
to findings consistent with chronic bile duct obstruction. 
Within 4-12 months of the initial cholestasis, a histological 
analysis shows uniformly progressive fibrosis of the IHD 
with bile duct proliferation, portal inflammatory infiltrates, 
periductal fibrosis, bridging fibrosis, and canalicular 
cholestasis. After 12-24 months, incipient or overt liver 
cirrhosis is usually diagnosed.
The cross-sectional imaging findings for SC-CIP in 
a retrospective literature review are multiple irregular 
strictures, dilatations, a beaded appearance, and wall 
thickening of IHD, which are mimicking primary sclerosing 
cholangitis (PSC) (2). Ruemmele et al. (7) and Esposito 
et al. (10) have reported that the earliest event in SC-CIP 
may be extensive biliary cast formation with subsequent 
infections, and this is represented by intraductal filling 
defects in MRCP and ERC. Several weeks after the initial 
cholestasis, multiple irregular strictures or dilatations 
with biliary cast formations can often be observed. In 
addition, they reported that several months after the initial 
injury, advancing rarefaction of the small bile ducts and 
progressive sclerosis can often be observed. In our case, 
an increase in intraluminal attenuation in the diffusely 
thickened right main IHD was suspicious on the CT exam, 
and it was confirmed as biliary casts on ERC. However, 
biliary casts in the peripheral IHD or left main IHD were 
not detected in the contrast-enhanced CT exam. The ability 
to evaluate biliary casts from a CT exam may be limited. 
Irregular elongated filling defects on MRCP and ERC, which 
are representative of biliary casts, were noted in both 
IHDs and extended to the proximal CBD. Multiple irregular 
strictures, dilatations, and saccular ectasia were also seen 
in both IHDs. However, there was no evidence of CBD 
stenosis or irregularities. Jaeger et al. (4) have reported 
that multifocal strictures and beading are only seen in the 
IHDs without CBD involvement and that biliary casts formed 
in the IHDs can extend to the CBD. This finding in our study 
was consistent with the ERC and MRCP findings of other SC-
CIP studies (2, 4, 6, 9). We believe that the SC-CIP imaging 
findings in the early stages are similar to those of typical 
sclerosing cholangitis, although biliary cast formation in 
the IHDs is not a typical finding in primary or other forms 
of secondary sclerosing cholangitis. In the later stages of 
SC-CIP, the cholangiography findings are similar to those 
of ischemic cholangitis and long-term PSC, which consisted 
of the destruction of the biliary tree rather than the usual 
sclerosing cholangitis (7, 8).
Radiologically, the differential diagnosis for biliary cast 
formation in SC-CIP includes ischemic cholangiopathy, 
PSC, and other forms of secondary sclerosing cholangitis. 
Ischemic cholangiopathy almost always occurs in 
transplanted livers as a consequence of complications and 
sometimes in other ischemic status, such as transarterial 
chemoembolization (TACE) complications or hepatic artery 
injury. However, it is still debatable whether SC-CIP is 
an ischemic-like cholangiopathy. Biliary cast formation 
is extremely rare in primary or other forms of secondary 
sclerosing cholangitis. In addition, most of the pathology 
in SC-CIP involves the IHD and spares the CBD. A clinical 
history that includes ICU hospitalization will be helpful for 
suggesting SC-CIP to a radiologist and for ruling out other 
causes of secondary sclerosing cholangitis.
With regard to the treatment of biliary casts in SC-CIP, 
endoscopic removal of as many as possible is recommended, 
and UDCA can also be used (6, 9). However, the progressive 
destruction of the biliary tree cannot be prevented; 
therefore, the only curative treatment option is liver 
transplantation. The prognosis for SC-CIP has not been 
established until recently. Gelbmann et al. (1) have reported 
that in the first two years after discharge from the hospital, 
eight of the 26 (30%) SC-CIP cases underwent liver 
transplantation or were waiting for liver transplantation, 
due to severe progressive cholestasis. Jaeger et al. (4) have 
reported that 45 months after the initial injury, one of the 
10 (10%) SC-CIP cases underwent liver transplantation, and 
eight patients appeared to have slowly progressive disease. 
A study has reported that SC-CIP rapidly progresses to liver 
cirrhosis with a median survival of only 13 months if the 
patient does not undergo liver transplantation (7). Although 
establishing the prognosis of SC-CIP is still ongoing, the 
progression of SC-CIP is even more aggressive than that of 
other forms of secondary sclerosing cholangitis.
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liver is rare. However, a diagnosis of SC-CIP should be 
considered in ICU patients with biliary cast formation and 
sclerosing cholangitis of the IHD in their CT, MRCP and ERC 
findings. 
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